Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC) Meeting Abstract
| Authors: | Loi, S.; Johnston, S.; Arteaga, C.; Graff, S.; Chandarlapaty, S.; Goetz, M.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; Sireci, A.; Sandoval, C.; Won, H.; Litchfield, L.; Turner, N. |
| Abstract Title: | Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC) |
| Meeting Title: | 19th St. Gallen International Breast Cancer Conference (2025) |
| Journal Title: | Breast |
| Volume: | 80 |
| Issue: | Suppl. |
| Meeting Dates: | 2025 Mar 12-15 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0960-9776 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2025-02-01 |
| Start Page: | 103902 |
| Language: | English |
| ACCESSION: | WOS:001450900400055 |
| DOI: | 10.1016/j.breast.2025.103902 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P008 -- Source: Wos |
